{"id":12784,"date":"2026-02-18T13:51:00","date_gmt":"2026-02-18T13:51:00","guid":{"rendered":"https:\/\/csiag.eu\/?p=12784"},"modified":"2026-02-18T14:26:28","modified_gmt":"2026-02-18T14:26:28","slug":"fotobiomodulacija-pbm","status":"publish","type":"post","link":"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/","title":{"rendered":"Fotobiomodul\u0101cija (PBM)"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_87_1 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Satura r\u0101d\u012bt\u0101js<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Einleitung\" >Ievads<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Indikationen_auf_einen_Blick\" >Indik\u0101cijas \u012bsum\u0101<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Haut_Wundheilung_Kollagen_660_nm\" >\u0100da, br\u016b\u010du dz\u012b\u0161ana un kolag\u0113ns (660 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews_Mechanismen\" >Visaptvero\u0161i p\u0101rskati un meh\u0101nismi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kollagensynthese_Hautverjungung\" >Kolag\u0113na sint\u0113ze un \u0101das atjauno\u0161ana<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Studien_Wundheilung_JAAD\" >Kl\u012bniskie p\u0113t\u012bjumi Br\u016b\u010du dz\u012b\u0161ana (JAAD)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Muskeln_Sport_Rehabilitation_850_nm\" >Musku\u013ci, sports un rehabilit\u0101cija (850 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Skelettmuskelregeneration\" >Skeleta musku\u013cu re\u0123ener\u0101cija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Meta-Analysen_Sportleistung_Muskelkater\" >Sporta snieguma un musku\u013cu s\u0101pju metaanal\u012bze<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\" >Smadzenes, izzi\u0146a un neirolo\u0123ija (810-1 064 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Mechanismen_allgemeine_Wirkungen\" >Meh\u0101nismi un visp\u0101r\u0113j\u0101 ietekme<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Alzheimer_Demenz\" >Alcheimera slim\u012bba un demence<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#TBI_Entgiftung_1064_nm\" >TBI un detoksik\u0101cija (1064 nm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Schmerzmanagement\" >S\u0101pju p\u0101rvald\u012bba<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews\" >Visaptvero\u0161i p\u0101rskati<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Fibromyalgie\" >Fibromial\u0123ija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kniearthrose_Tendinopathie\" >Ce\u013ca osteoartr\u012bts un tendinop\u0101tija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neuropathischer_Schmerz\" >Neirop\u0101tisk\u0101s s\u0101pes<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_AMD\" >Oftalmolo\u0123ija (AMD)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Altersbedingte_Makuladegeneration\" >Ar vecumu saist\u012bta makulas de\u0123ener\u0101cija<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_Mukositis\" >Onkolo\u0123ija un mukoz\u012bts<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Leitlinien\" >Vadl\u012bnijas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Chemotherapie-induzierte_Mukositis\" >\u0136\u012bmijterapijas izrais\u012bts mukoz\u012bts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kopf-Hals-Karzinome_Strahlentherapie\" >Galvas un kakla v\u0113zis un staru terapija<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunsystem_Entzundung\" >Im\u016bnsist\u0113ma un iekaisums<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunmodulation\" >Im\u016bnmodul\u0101cija<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Empfehlungen\" >Kl\u012bniskie ieteikumi<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Dosierungsregeln_Konsensus\" >Visp\u0101r\u012bgi doz\u0113\u0161anas noteikumi (vienpr\u0101t\u012bba)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Evidenzstarke_nach_Bereich\" >Pier\u0101d\u012bjumu stiprums pa jom\u0101m<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\" >Sazi\u0146a ar PBM lietot\u0101jiem - \u0101rstiem \/ kl\u012bnik\u0101m<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\" >Oftalmolo\u0123ija - saus\u0101 AMD (makulas de\u0123ener\u0101cija)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\" >Onkolo\u0123ija - mutes g\u013cot\u0101das iekaisums (\u0137\u012bmijterapijas\/radioterapijas sekas)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\" >Dermatolo\u0123ija - \u0101da, br\u016b\u010du dz\u012b\u0161ana, pinnes, psori\u0101ze<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Zahnmedizin_MKG-Chirurgie\" >Zob\u0101rstniec\u012bba \/ sejas un \u017eok\u013cu \u0137irur\u0123ija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\" >Neirolo\u0123ija \/ psihiatrija - Alcheimera slim\u012bba, TBI, depresija (agr\u012bn\u0101 f\u0101ze)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Suchwerkzeuge\" >Visp\u0101r\u0113jie mekl\u0113\u0161anas r\u012bki<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Las\u012b\u0161anas laiks<\/span> <span class=\"rt-time\"> 12<\/span> <span class=\"rt-label rt-postfix\">protokols<\/span><\/span>\n<p class=\"wp-block-paragraph\">Visaptvero\u0161s p\u0113t\u012bjuma p\u0101rskats 2023-2025<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Einleitung\"><\/span>Ievads<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Fotobiomodul\u0101cija (PBM), kas paz\u012bstama ar\u012b k\u0101 zema l\u012bme\u0146a l\u0101zerterapija (LLLT), ir neinvaz\u012bva terapeitiska metode, kur\u0101 izmanto noteikta vi\u013c\u0146u garuma gaismu, lai stimul\u0113tu biolo\u0123iskos procesus dz\u012bvos audos.<br>Galvenais meh\u0101nisms ir fotonu absorbcija mitohondri\u0101laj\u0101 fotoakceptor\u0101. <em>Citohroma c oksid\u0101ze<\/em> (CCO), kas ir <em>ATP sint\u0113ze<\/em> modul\u0113 reakt\u012bv\u0101s sk\u0101bek\u013ca sugas un izraisa \u0161\u016bnu re\u0123ener\u0101cijas procesu kask\u0101di.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Terapeitiski noz\u012bm\u012bgais \u201eoptiskais logs\u201c ir no 600 l\u012bdz 1100 nm. Tr\u012bs kl\u012bniski \u012bpa\u0161i svar\u012bgi vi\u013c\u0146u garumi ir \u0161\u0101di:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>660 nm<\/strong><br>Iek\u013c\u016b\u0161anas dzi\u013cums 1-10 mm, jaudas bl\u012bvums 6-50 mW\/cm\u00b2<br>Ide\u0101li piem\u0113rots \u0101dai, br\u016b\u010du dz\u012b\u0161anai un virspus\u0113jiem audiem.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>850 nm<\/strong><br>Iek\u013c\u016b\u0161anas dzi\u013cums l\u012bdz 50 mm, jaudas bl\u012bvums 50-100 mW\/cm\u00b2<br>Piem\u0113rots musku\u013ciem, loc\u012btav\u0101m un dzi\u013c\u0101k\u0101m strukt\u016br\u0101m.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1 050-1 064 nm<\/strong><br>Dzi\u013ca iek\u013c\u016b\u0161ana audos, jaudas bl\u012bvums 25-285 mW\/cm\u00b2 (transkrani\u0101li)<br>Attiecas uz neirolo\u0123iju, smadze\u0146u un oftalmolo\u0123iju.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dozas noteik\u0161anas pamatprincips ir \u0161\u0101ds <em>Arnda un \u0160ulca l\u012bkne<\/em> (Horm\u0113sis):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>P\u0101r\u0101k maz gaismas nav efekta, optim\u0101l\u0101 deva stimul\u0113<\/li>\n\n\n\n<li>P\u0101r\u0101k liels daudzums iedarbojas nom\u0101co\u0161i vai boj\u0101jo\u0161i uz \u0161\u016bn\u0101m.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160\u012b divf\u0101zu sakar\u012bba izskaidro, k\u0101p\u0113c veiksm\u012bgai terapijai ir \u013coti svar\u012bga pareiza jaudas bl\u012bvuma un ener\u0123ijas bl\u012bvuma noteik\u0161ana.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Indikationen_auf_einen_Blick\"><\/span>Indik\u0101cijas \u012bsum\u0101<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Turpm\u0101kaj\u0101 tabul\u0101 apkopoti kl\u012bniskajos p\u0113t\u012bjumos izmantotie parametri (vi\u013c\u0146a garums, jaudas bl\u012bvums, ener\u0123ijas bl\u012bvums, ilgums, frekvence) katrai \u0101rst\u0113\u0161anas zonai. <br>Avoti: Hamblin\/Harvard (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noreferrer noopener\">PMC8355782<\/a>), <a href=\"https:\/\/waltpbm.org\/\" target=\"_blank\" rel=\"noopener\">WALT vadl\u012bnijas<\/a>, kl\u012bniskie p\u0113t\u012bjumi 2020-2025.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Nor\u0101de<\/strong><\/td><td><strong>Vi\u013c\u0146a garums<\/strong><\/td><td><strong>Jaudas bl\u012bvums<\/strong><\/td><td><strong>Ener\u0123ijas bl\u012bvums<\/strong><\/td><td><strong>Ilgums \/ sesija<\/strong><\/td><td><strong>Bie\u017eums<\/strong><\/td><\/tr><\/thead><tbody><tr><td>\u0100da \/ Kolag\u0113ns<\/td><td>660 nm<\/td><td>6-50 mW\/cm\u00b2<\/td><td>8-16 J\/cm\u00b2<\/td><td>10-21 min<\/td><td>2-3\u00d7 ned\u0113\u013c\u0101<\/td><\/tr><tr><td>Br\u016b\u010du dz\u012b\u0161ana<\/td><td>630-660 nm<\/td><td>10-50 mW\/cm\u00b2<\/td><td>4-15 J\/cm\u00b2<\/td><td>7-20 min<\/td><td>katru dienu - 3\u00d7 ned\u0113\u013c\u0101<\/td><\/tr><tr><td>Musku\u013cu re\u0123ener\u0101cija<\/td><td>808-850 nm<\/td><td>50-100 mW\/cm\u00b2<\/td><td>10-30 J\/cm\u00b2<\/td><td>5-15 min<\/td><td>tie\u0161i pirms\/p\u0113c sporta<\/td><\/tr><tr><td>Hroniskas s\u0101pes<\/td><td>630-905 nm<\/td><td>40-100 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 min<\/td><td>3\u00d7 ned\u0113\u013c\u0101, 6-12 ned\u0113\u013cas.<\/td><\/tr><tr><td>Fibromial\u0123ija<\/td><td>630-1 100 nm (viss \u0137ermenis)<\/td><td>main\u012bgais<\/td><td>1-150 J\/cm\u00b2<\/td><td>15-30 min\u016btes<\/td><td>2-3\u00d7 ned\u0113\u013c\u0101, 4-6 ned\u0113\u013cas.<\/td><\/tr><tr><td>Ce\u013ca osteoartr\u012bts<\/td><td>630-850 nm<\/td><td>40-80 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 min<\/td><td>3\u00d7 ned\u0113\u013c\u0101<\/td><\/tr><tr><td>Smadzenes \/ Izzi\u0146a<\/td><td>810-1 064 nm (transkrani\u0101li)<\/td><td>25-285 mW\/cm\u00b2<\/td><td>20-60 J\/cm\u00b2<\/td><td>10-20 min<\/td><td>3\u00d7 ned\u0113\u013c\u0101<\/td><\/tr><tr><td>AMD \/ acs<\/td><td>590 + 660 + 850 nm<\/td><td>0,3-15 \u03bcW\/cm\u00b2 (t\u012bklene)<\/td><td>\u013boti zems<\/td><td>3-10 min \/ sesija<\/td><td>3\u00d7 ned\u0113\u013c\u0101 l\u012bdz ikdien\u0101<\/td><\/tr><tr><td>Mukoz\u012bts (onkolo\u0123ija)<\/td><td>630-660 nm<\/td><td>10-25 mW\/cm\u00b2<\/td><td>2-6 J\/cm\u00b2<\/td><td>3-5 min \/ punkts<\/td><td>katru dienu terapijas laik\u0101<\/td><\/tr><tr><td>Im\u016bnmodul\u0101cija \/ iekaisums<\/td><td>650-950 nm<\/td><td>main\u012bgais<\/td><td>1-10 J\/cm\u00b2<\/td><td>5-15 min<\/td><td>3\u00d7 ned\u0113\u013c\u0101<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Jaudas bl\u012bvums = izstarojums (mW\/cm\u00b2) audu virsm\u0101.<\/em><br><em>Ener\u0123ijas bl\u012bvums = fluence (J\/cm\u00b2) vien\u0101 sesij\u0101.<\/em><br><em>AMD: t\u012bklenes apstaro\u0161anas v\u0113rt\u012bbas ir iev\u0113rojami zem\u0101kas nek\u0101 \u0101das virsmas v\u0113rt\u012bbas.<\/em><br><em><strong>Piez\u012bme<\/strong>Nav vienota starptautiska standarta - v\u0113rt\u012bbas atspogu\u013co vienpr\u0101t\u012bbu, kas pan\u0101kta metaanal\u012bz\u0113s un WALT ieteikumos.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Haut_Wundheilung_Kollagen_660_nm\"><\/span>\u0100da, br\u016b\u010du dz\u012b\u0161ana un kolag\u0113ns (660 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Sarkano gaismu pie 660 nm \u012bpa\u0161i efekt\u012bvi absorb\u0113 \u0101das hromofori, un t\u0101 aktiviz\u0113 kolag\u0113na sint\u0113zi fibroblastos, regul\u0113jot COL1A1 un COL3A1 g\u0113nu ekspresiju, k\u0101 ar\u012b MMP-9 un NO izdal\u012b\u0161anos. Iek\u013c\u016b\u0161anas dzi\u013cums: 1-10 mm (epiderma, derma, hipoderma). Divf\u0101zu devas modelis ir \u012bpa\u0161i izteikts \u0101das audos: ener\u0123ijas bl\u012bvums virs 20 J\/cm\u00b2 var izrais\u012bt oksidat\u012bvo stresu un atgriezenisku kolag\u0113na stimul\u0101ciju.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 660 nm (ar\u012b 630-680 nm)<\/li>\n\n\n\n<li>Jaudas bl\u012bvums 6-50 mW\/cm\u00b2 (LED: 6-30; l\u0101zers: 30-50).<\/li>\n\n\n\n<li>Ener\u0123ijas bl\u012bvums 8-16 J\/cm\u00b2 (optim\u0101lais)<\/li>\n\n\n\n<li>Ilgums 10-21 min | 3\u00d7 ned\u0113\u013c\u0101<\/li>\n\n\n\n<li>Vismaz 8 ned\u0113\u013cas \u0101das atjauno\u0161anai; 4 ned\u0113\u013cas br\u016b\u010du dzied\u0113\u0161anai.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews_Mechanismen\"><\/span>Visaptvero\u0161i p\u0101rskati un meh\u0101nismi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>No gaismas l\u012bdz dziedin\u0101\u0161anai: fotobiomodul\u0101cijas terapija medic\u012bnas discipl\u012bn\u0101s<\/strong><br><em>Journal of Translational Medicine (2025)<\/em><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12751248\/\" target=\"_blank\" rel=\"noopener\"> Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Visaptvero\u0161s p\u0101rskats, kur\u0101 apvienota fotofizika, mitohondriju biolo\u0123ija un kl\u012bnisk\u0101 rehabilit\u0101cija. PBM pie 600-1 100 nm aktiviz\u0113 paaugstin\u0101tu ATP sint\u0113zi un kontrol\u0113tu ROS signaliz\u0113\u0161anu ar CCO starpniec\u012bbu, kas aktiviz\u0113 transkripcijas faktorus (NF-\u03baB, AP-1, HIF-1\u03b1) un regul\u0113 aug\u0161anas faktorus (TGF-\u03b2, VEGF, IGF-1). Audu l\u012bmen\u012b tiek veicin\u0101ta fibroblastu un keratinoc\u012btu prolifer\u0101cija, makrof\u0101gu polariz\u0101cija un kolag\u0113na sint\u0113ze. Visb\u016btisk\u0101k\u0101 ieteicam\u0101 deva audiem ar zemu mitohondriju saturu (\u0101da, c\u012bpslas): Jaudas bl\u012bvums &lt; 100 mW\/cm\u00b2, ener\u0123ijas bl\u012bvums 4-10 J\/cm\u00b2 m\u0113r\u0137a audos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Gaismas sp\u0113ka atkl\u0101\u0161ana \u0101dai: visaptvero\u0161s p\u0101rskats par fotobiomodul\u0101ciju<\/strong><br><em>Int. J. Mol. Sci. (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/25\/8\/4483\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kl\u012bnisko p\u0113t\u012bjumu (6 gadi) par PBM dermatolo\u0123ij\u0101 apraksto\u0161s p\u0101rskats. Visbie\u017e\u0101k izmantoja 630-950 nm vi\u013c\u0146u garumu. Optim\u0101lais \u0101das atjauno\u0161anai: 630-660 nm, 6-50 mW\/cm\u00b2, 8-16 J\/cm\u00b2, 3 reizes ned\u0113\u013c\u0101. Bikini divf\u0101zu efekts: lab\u0101kie rezult\u0101ti ar m\u0113ren\u0101m un vid\u0113j\u0101m dev\u0101m; p\u0101rdoz\u0113\u0161ana (&gt; 20 J\/cm\u00b2 uz \u0101das virsmas) var kav\u0113t kolag\u0113na sint\u0113zi, nevis to veicin\u0101t.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kollagensynthese_Hautverjungung\"><\/span>Kolag\u0113na sint\u0113ze un \u0101das atjauno\u0161ana<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Zema l\u012bme\u0146a gaismas terapijas optimiz\u0113\u0161ana \u0101das atjauno\u0161anai<\/strong><br><em>SCIRP (2025)<\/em> <a href=\"https:\/\/www.scirp.org\/journal\/paperinformation?paperid=142513\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT (ar dal\u012btu seju) ar 830 nm + 633 nm LED. Parametri: 6,4 mW\/cm\u00b2, 8,05 J\/cm\u00b2, 21 min\u016bte vien\u0101 seans\u0101, 3 reizes ned\u0113\u013c\u0101 4 ned\u0113\u013cas. Iev\u0113rojama grumbu samazin\u0101\u0161an\u0101s un \u0101das elast\u012bbas uzlabo\u0161an\u0101s. Galvenais atkl\u0101jums: 3 seansi ned\u0113\u013c\u0101 bija efekt\u012bv\u0101ki nek\u0101 2 - bie\u017eums b\u016btiski ietekm\u0113ja rezult\u0101tu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u0100das kolag\u0113na metabolisma regul\u0113\u0161ana, izmantojot 660 nm gaismas diodi<\/strong><br><em>Journal of Investigative Dermatology (klasisks p\u0113t\u012bjums)<\/em><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022202X15341749\" target=\"_blank\" rel=\"noopener\"> Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>660 nm, impulsa (sec\u012bga impulsa re\u017e\u012bma LED)<\/li>\n\n\n\n<li>11 san\u0101ksmes<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rezult\u0101ti<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>+31% 1. tipa prokolag\u0113ns<\/li>\n\n\n\n<li>-18% MMP-1 audu biopsij\u0101s.<\/li>\n\n\n\n<li>&gt;90% no visiem testa subjektiem samazin\u0101j\u0101s grumbu dzi\u013cums.<\/li>\n\n\n\n<li>Fotobiolo\u0123iskajai efektivit\u0101tei noteico\u0161ais bija sec\u012bgo impulsu modelis (nevis nep\u0101rtrauktais vilnis).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Studien_Wundheilung_JAAD\"><\/span>Kl\u012bniskie p\u0113t\u012bjumi Br\u016b\u010du dz\u012b\u0161ana (JAAD)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotobiomodul\u0101cijas CME II da\u013ca: Kl\u012bniskie pielietojumi dermatolo\u0123ij\u0101<\/strong><br><em>Amerikas Dermatolo\u0123ijas akad\u0113mijas \u017eurn\u0101ls (2024)<\/em> <a href=\"https:\/\/www.jaad.org\/article\/S0190-9622(24)00187-7\/fulltext\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&gt;20 ekspertu konsenss (JAAD). Diab\u0113tisko \u010d\u016blu parametri (pier\u0101d\u012bjumu l\u012bmenis IA): 630-670 nm, 10-50 mW\/cm\u00b2, 2-6 J\/cm\u00b2, lieto katru dienu vai 3 reizes ned\u0113\u013c\u0101 l\u012bdz br\u016bces sl\u0113g\u0161anai. 12 RCT metaanal\u012bze: \u010d\u016blas laukums -30,9%, -4,2 cm\u00b2 sal\u012bdzin\u0101jum\u0101 ar kontroli. Pozit\u012bvi ietekm\u0113tas visas br\u016b\u010du dz\u012b\u0161anas f\u0101zes (iekaisuma, prolifer\u0101cijas, remodel\u0101cijas).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM terapijas (660 nm) ietekme uz Staphylococcus aureus infic\u0113tu br\u016b\u010du dz\u012b\u0161anu<\/strong><br><em>Fotobiomodulis Photomed Laser Surg. (2020)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32466696\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">P\u0113t\u012bjums ar dz\u012bvniekiem: 660 nm, 35 min\u016btes dien\u0101, 7 dienas. Iev\u0113rojami maz\u0101kas br\u016bces (p &lt; 0,01), vair\u0101k granul\u0113jo\u0161o audu, augst\u0101kais kolag\u0113na saturs (3+ pak\u0101pe). PCNA prolifer\u0101cijas mar\u0137ieri iev\u0113rojami palielin\u0101j\u0101s. Piez\u012bme: intensit\u0101te apzin\u0101ti saglab\u0101ta zema - infic\u0113t\u0101s br\u016bc\u0113s ir \u012bpa\u0161i svar\u012bgi nep\u0101rsniegt devu (&lt; 15 J\/cm\u00b2).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Muskeln_Sport_Rehabilitation_850_nm\"><\/span>Musku\u013ci, sports un rehabilit\u0101cija (850 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Tuv\u0101 infrasarkan\u0101 starojuma gaisma, kuras vi\u013c\u0146u garums ir 850 nm, iek\u013c\u016bst l\u012bdz pat 50 mm dzi\u013cum\u0101. Saska\u0146\u0101 ar metaanal\u012bzi (Baroni et al., 2019) optim\u0101lais parametrs musku\u013cu aplik\u0101cij\u0101m ir 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2 - tren\u0113tiem sportistiem tika izm\u0113r\u012bts 15% sp\u0113ka pieaugums. Ja devas ir p\u0101r\u0101k lielas (&gt; 50 J\/cm\u00b2, &gt; 200 mW\/cm\u00b2), efekts samazin\u0101s. Leal-Junior et al. p\u0113t\u012bjum\u0101 (2011) tika noteikta optim\u0101l\u0101 810 nm deva - 30 J kop\u0101 (nevis J\/cm\u00b2) 6 musku\u013cu punktos pirms treni\u0146a.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 808-850 nm<\/li>\n\n\n\n<li>Jaudas bl\u012bvums 50-100 mW\/cm\u00b2 (l\u0101zers); 30-150 mW\/cm\u00b2 (LED panelis).<\/li>\n\n\n\n<li>Ener\u0123ijas bl\u012bvums 10-30 J\/cm\u00b2 (sportistiem); 6-10 J\/cm\u00b2 (rehabilit\u0101cijai).<\/li>\n\n\n\n<li>Ilgums 5-15 min\/musku\u013cu grupai<br>Lieto\u0161ana tie\u0161i pirms vai p\u0113c treni\u0146a<\/li>\n\n\n\n<li>3-7\u00d7 ned\u0113\u013c\u0101 intens\u012bvai apm\u0101c\u012bbai; 2-3\u00d7 ned\u0113\u013c\u0101 rehabilit\u0101cijai.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Skelettmuskelregeneration\"><\/span>Skeleta musku\u013cu re\u0123ener\u0101cija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBMT skeleta musku\u013cu re\u0123ener\u0101cij\u0101: visaptvero\u0161s p\u0101rskats<\/strong><br><em>Fotodiagnostika un fotodinamisk\u0101 terapija (2025)<\/em> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1572100025001668\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Galvenais p\u0113t\u012bjums (Baroni 2019): 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2, 6 musku\u013cu punkti \u2192 15% sp\u0113ka pieaugums sportistiem. IL-6 samazin\u0101jums par 40% ar profilaktisko PBM (5 J\/cm\u00b2 uz \u017eurku stilba kaula). Br\u012bdin\u0101jums: P\u0113t\u012bjumos ar dz\u012bvniekiem ieg\u016btie parametri (piem\u0113ram, 5 J\/cm\u00b2) nav tie\u0161i p\u0101rnesami uz cilv\u0113kiem - cilv\u0113ka kvadricepsa muskulim nepiecie\u0161ama liel\u0101ka ener\u0123ijas bl\u012bvuma jauda, jo audi ir dzi\u013c\u0101k.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM cilv\u0113ka musku\u013cu audos: priek\u0161roc\u012bba sporta rezult\u0101tos?<\/strong><br><em>J. Biophotonics (PMC) (2016)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5167494\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Visu RCT (1.b l\u012bmenis) un gad\u012bjumu kontroles p\u0113t\u012bjumu (3.b l\u012bmenis) sistem\u0101tisks p\u0101rskats. Visefekt\u012bv\u0101kie parametri bicepsam: 810-850 nm, 50-100 mW\/cm\u00b2, 10-30 J\/cm\u00b2. Efekt\u012bv\u0101kie parametri kvadricepsa (liel\u0101ks muskulis, dzi\u013c\u0101ki audi): nepiecie\u0161amas liel\u0101kas ener\u0123ijas, v\u0113lami klasteru aplikatori (5 diodes). PBM pirms treni\u0146a ir vismaz l\u012bdzv\u0113rt\u012bgs, bie\u017ei vien lab\u0101ks par p\u0113ctreni\u0146a pielietojumu attiec\u012bb\u0101 uz sp\u0113ka v\u0113rt\u012bb\u0101m.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Meta-Analysen_Sportleistung_Muskelkater\"><\/span>Sporta snieguma un musku\u013cu s\u0101pju metaanal\u012bze<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotomodul\u0101cijas terapijas ietekme uz DOMS: sistem\u0101tisks p\u0101rskats un metaanal\u012bze<\/strong><br><em>MDPI JFMK (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2411-5142\/10\/3\/277\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14 p\u0113t\u012bjumi, vi\u013c\u0146u garums 660-950 nm, 1-6 musku\u013cu punkti. Optim\u0101lais DOMS mazin\u0101\u0161anai: 830-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2 katr\u0101 punkt\u0101, uzreiz p\u0113c treni\u0146a. Iev\u0113rojams VAS s\u0101pju samazin\u0101jums sal\u012bdzin\u0101jum\u0101 ar placebo; pozit\u012bva ietekme uz musku\u013cu sp\u0113ka saglab\u0101\u0161anu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vai PBM pirms treni\u0146a var uzlabot musku\u013cu iztur\u012bbu un veicin\u0101t atvese\u013co\u0161anos? Metaanal\u012bze<\/strong><br><em>L\u0101zeri medic\u012bnas zin\u0101tn\u0113 (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38758297\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kreat\u012bnkin\u0101zes l\u012bmenis samazin\u0101j\u0101s par 77,56 vien\u012bb\u0101m (95%-KI: -112,67 l\u012bdz -42,44, p &lt; 0,01). Visefekt\u012bv\u0101kie parametri: 810 nm, 200 mW kop\u0113j\u0101 jauda, 30 J kop\u0113j\u0101 ener\u0123ija uz 6 kvadricepsa punktiem. Divf\u0101zu secin\u0101jums: 50 J kop\u0113j\u0101 ener\u0123ija bija maz\u0101k efekt\u012bva nek\u0101 30 J - skaidrs Hormesa\/Arndt-Schulza l\u012bknes piem\u0113rs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM pirms treni\u0146a (810 nm): Optim\u0101la jauda musku\u013cu atvese\u013co\u0161anai<\/strong><br><em>Photomed Laser Surg (2017)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29099680\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT ar 28 futbola sportistiem. Sal\u012bdzin\u0101ja 100, 200, 400 mW jaudu uz diodi (5 diodes, 810 nm). Rezult\u0101ts: 100 mW uz diodi (500 mW kop\u0101) bija optim\u0101ls rezult\u0101ts. Liel\u0101ka jauda (200, 400 mW) neuzr\u0101d\u012bja lab\u0101kus vai pat slikt\u0101kus rezult\u0101tus - klasisks piem\u0113rs: liel\u0101ks jaudas bl\u012bvums autom\u0101tiski nav lab\u0101ks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM, IPC un NMES ietekme uz musku\u013cu atjauno\u0161anos: sistem\u0101tisks p\u0101rskats<\/strong><br><em>Journal of Bodywork and Movement Therapies (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954632\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">19 RCT, 672 dal\u012bbnieki. PBM pirms apm\u0101c\u012bbas samazin\u0101ja s\u0101pes par -12,27 punktiem (95%-KI -18,14 l\u012bdz -6,40; I\u00b2 = 48%). PBM bija vien\u012bg\u0101 metode (sal\u012bdzin\u0101jum\u0101 ar IPC un NMES), kas deva b\u016btisku ieguvumu. Ieteicamie parametri: 810-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\"><\/span>Smadzenes, izzi\u0146a un neirolo\u0123ija (810-1 064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Transkrani\u0101lajai PBM j\u0101p\u0101rvar vair\u0101kas biolo\u0123isk\u0101s barjeras (galvas \u0101da, galvaskausa kauli, apvalki, muguras smadze\u0146u \u0161\u0137idrums, galvas smadze\u0146u garoza). T\u0101p\u0113c nepiecie\u0161am\u0101 jauda ir iev\u0113rojami liel\u0101ka nek\u0101 virspus\u0113jiem lietojumiem. Sistem\u0101tisk\u0101 2024. gada p\u0101rskat\u0101 (97 p\u0113t\u012bjumi, 2133 avoti) konstat\u0113ts: P\u0113t\u012bjumos parasti izmanto ~ 250 mW\/cm\u00b2 uz virsmas, no kuriem tikai neliela da\u013ca sasniedz smadze\u0146u audus. Kortik\u0101lajiem neironiem: optim\u0101la ATP ra\u017eo\u0161ana pie 25 mW\/cm\u00b2, 3 J\/cm\u00b2. Mitohondriju boj\u0101jumi rodas jau pie 30 J\/cm\u00b2 (p\u0101r\u0101k liela deva = nom\u0101co\u0161a).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 810 nm (izzi\u0146as\/ Alcheimera slim\u012bba), 1064 nm (dzi\u013ca iek\u013c\u016b\u0161ana\/TBI)<\/li>\n\n\n\n<li>Jaudas bl\u012bvums galvas \u0101d\u0101 25-285 mW\/cm\u00b2 (m\u0113r\u0137a audi: galvas garoza sa\u0146em da\u013cu no \u0161\u012bs jaudas).<\/li>\n\n\n\n<li>Ener\u0123ijas bl\u012bvums 20-60 J\/cm\u00b2 (virsma); 3 J\/cm\u00b2 m\u0113r\u0137a audos (neironi).<\/li>\n\n\n\n<li>Ilgums 10-20 min | 3 reizes ned\u0113\u013c\u0101 (Alcheimera slim\u012bbas RCT - 12 ned\u0113\u013cas)<\/li>\n\n\n\n<li>Vismaz 8-12 ned\u0113\u013cas kognit\u012bv\u0101s iedarb\u012bbas gad\u012bjum\u0101; ak\u016bt\u0101 iedarb\u012bba no 1-2 ned\u0113\u013c\u0101m TBI gad\u012bjum\u0101.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanismen_allgemeine_Wirkungen\"><\/span>Meh\u0101nismi un visp\u0101r\u0113j\u0101 ietekme<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Smadze\u0146u fotobiomodul\u0101cijas terapija: revolucioniz\u0113t kognit\u012bvo dinamiku<\/strong><br><em>MDPI \u0161\u016bnas (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/966\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PBM aktiviz\u0113 citohroma c oksid\u0101zi neironu mitohondrijos, palielina BDNF. 810 nm uzr\u0101da sp\u0113c\u012bg\u0101ku CCO aktiv\u0101ciju nek\u0101 1064 nm (CCO absorbcijas maksimums pie ~ 810 nm). Savuk\u0101rt 1 064 nm ir sp\u0113c\u012bg\u0101ka ietekme uz Ca\u00b2\u207a kan\u0101liem. Vienpr\u0101t\u012bba par kl\u012bniskajiem parametriem: 810 nm, 250 mW\/cm\u00b2 virsmas laukums, 20-60 J\/cm\u00b2, transkrani\u0101li uz prefront\u0101lo garozu un tempor\u0101lo daivu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Smadze\u0146u PBM narat\u012bva p\u0101rskats: Meh\u0101nismi, devas, n\u0101kotnes tendences<\/strong><br><em>PMC (Brain Photobiomodulation Review) (2018)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6041198\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Galvenie parametri: Kortik\u0101lie neironi (kultiv\u0113ti): 25 mW\/cm\u00b2, optim\u0101la ATP ra\u017eo\u0161ana pie 3 J\/cm\u00b2. Liel\u0101kas devas (10 J\/cm\u00b2) stimul\u0113 maz\u0101k, 30 J\/cm\u00b2 izraisa mitohondriju boj\u0101jumus. Dzi\u013c\u0101kajiem smadze\u0146u re\u0123ioniem (baz\u0101lie gangliji, smadze\u0146u stumbrs Parkinsona slim\u012bbas gad\u012bjum\u0101): Ieteicams 4. klases l\u0101zers (10-15 W), nevis 3. klases l\u0101zers (&lt;0,5 W), lai nodro\u0161in\u0101tu pietiekamu fluenci dzi\u013cumos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Alzheimer_Demenz\"><\/span>Alcheimera slim\u012bba un demence<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Smadze\u0146u PBM: iesp\u0113jam\u0101 Alcheimera un Parkinsona slim\u012bbas \u0101rst\u0113\u0161ana<\/strong><br><em>PMC (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12321612\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Prekl\u012bniskie p\u0113t\u012bjumi: 808-810 nm, puls\u0113jo\u0161i (40 Hz), katru dienu vai 3 reizes ned\u0113\u013c\u0101, 12 ned\u0113\u013cas. Uzr\u0101d\u012bta beta amilo\u012bda samazin\u0101\u0161an\u0101s, oks. Stresa, neiroinflammation; lab\u0101ki kognit\u012bvie r\u0101d\u012bt\u0101ji dz\u012bvnieku model\u012b. Kl\u012bnisks p\u0113t\u012bjums (Jap\u0101na): puls\u0113jo\u0161\u0101 810 nm gaisma (40 Hz), 3 reizes ned\u0113\u013c\u0101, 12 ned\u0113\u013cas, rezult\u0101ts: iev\u0113rojami uzlaboti ADAS-Cog r\u0101d\u012bt\u0101ji.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Transkrani\u0101l\u0101 PBM Alcheimera slim\u012bbas gad\u012bjum\u0101: RCT protokols (Jap\u0101na)<\/strong><br><em>Neirolo\u0123ijas robe\u017eas (2024)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11258032\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Piln\u012bb\u0101 aprakst\u012bti RCT parametri: 810 nm, 40 Hz impulss, 250 mW\/cm\u00b2, 20 min\/sesija, 3 reizes ned\u0113\u013c\u0101, 12 ned\u0113\u013cas. EEG m\u0113r\u012bjumi par\u0101d\u012bja alfa\/beta\/gamma ritma uzlabo\u0161anos. Prim\u0101rais gal\u012bgais r\u0101d\u012bt\u0101js ADAS-Cog (Alcheimera izzi\u0146as skala). Perspekt\u012bvs fikt\u012bvs kontrol\u0113ts p\u0113t\u012bjums.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Transkrani\u0101lais PBM uzlabo kognit\u012bv\u0101s funkcijas, PTSD un postkons\u016bzijas simptomus<\/strong><br><em>Journal of Neurotrauma (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40485299\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT, 17 TBI pacienti. Parametri: 810 nm vai 1064 nm, 250 mW\/cm\u00b2, 20 J\/cm\u00b2, 10 min\/sesija. Iev\u0113rojami kognit\u012bvo funkciju, PTSS un p\u0113c satricin\u0101juma simptomu uzlabojumi. Placebo kontrol\u0113ta.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"TBI_Entgiftung_1064_nm\"><\/span>TBI un detoksik\u0101cija (1064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1064 nm PBM veicina TBI atvese\u013co\u0161anos, modul\u0113jot neirona iekaisumu<\/strong><br><em>Journal of Translational Medicine (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41204266\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Peles modelis: 1064 nm LED, 25 mW\/cm\u00b2, 12 min\/dien\u0101 (= 18 J\/cm\u00b2), 14 dienas. Iev\u0113rojama atvese\u013co\u0161an\u0101s p\u0113c TBI, kognit\u012bvo un emocion\u0101lo trauc\u0113jumu mazin\u0101\u0161an\u0101s. BDNF un VEGF iev\u0113rojami palielin\u0101j\u0101s \u0101rst\u0113\u0161anas zon\u0101. Meh\u0101nisms: mikroglijas polariz\u0101cijas un neiroinflammation modul\u0101cija.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM un glimf\u0101tisk\u0101 sist\u0113ma: smadze\u0146u limfas dren\u0101\u017eas uzlabo\u0161ana<\/strong><br><em>Int. J. Mol. Sci. (2022)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8950470\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">P\u0113t\u012bjumi ar dz\u012bvniekiem: PBM (810 nm, 25-50 mW\/cm\u00b2) uzlabo meninge\u0101lo limfas pl\u016bsmu, veicina beta amilo\u012bda kl\u012brensu caur glimf\u0101tisko sist\u0113mu. Terapeitisk\u0101 noz\u012bme: smadze\u0146u detoksik\u0101cijas funkcija - svar\u012bgi Alcheimera slim\u012bbas profilaksei un visp\u0101r\u0113jai smadze\u0146u vesel\u012bbai.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Schmerzmanagement\"><\/span>S\u0101pju p\u0101rvald\u012bba<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM ir analg\u0113tiska iedarb\u012bba, izmantojot vair\u0101kus meh\u0101nismus: proiekaisuma citok\u012bnu (TNF-\u03b1, IL-6, IL-1\u03b2) samazin\u0101\u0161anos, nocicept\u012bvo C un A\u03b4 \u0161\u0137iedru modul\u0101ciju, endorf\u012bna izdal\u012b\u0161an\u0101s palielin\u0101\u0161anos un viet\u0113j\u0101s mikrocirkul\u0101cijas uzlabo\u0161anos. Virspus\u0113jiem s\u0101pju punktiem (jut\u012bgie punkti, spriedzes punkti): pietiek ar 630-660 nm. Dzi\u013c\u0101k\u0101m musku\u013cu un skeleta strukt\u016br\u0101m (loc\u012btav\u0101m, mugurkaulam): 780-905 nm ar liel\u0101ku jaudas bl\u012bvumu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 630-905 nm (atkar\u012bb\u0101 no s\u0101pju punkta dzi\u013cuma)<\/li>\n\n\n\n<li>Jaudas bl\u012bvums 40-100 mW\/cm\u00b2 (virspus\u0113jais: 40-60; dzi\u013cais: 60-100).<\/li>\n\n\n\n<li>Ener\u0123ijas bl\u012bvums 4-10 J\/cm\u00b2 katr\u0101 punkt\u0101 (fibromial\u0123ijai: l\u012bdz 150 J\/cm\u00b2 vis\u0101 \u0137ermen\u012b).<\/li>\n\n\n\n<li>Ilgums 10-20 min\/sesija<\/li>\n\n\n\n<li>Bie\u017eums 3 reizes ned\u0113\u013c\u0101, 6-12 ned\u0113\u013cas; fibromial\u0123ija: 4-6 ned\u0113\u013cas intens\u012bvi + turpm\u0101k\u0101 uzraudz\u012bba.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews\"><\/span>Visaptvero\u0161i p\u0101rskati<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM ietekme uz vair\u0101kiem vesel\u012bbas rezult\u0101tiem: visaptvero\u0161s RCT p\u0101rskats<\/strong><br><em>Sistem\u0101tiskie apskati (Springer) (2025)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02902-3\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">15 metaanal\u012bzes, &gt; 9000 pacientu, 35 beigu punkti, 15 slim\u012bbas. Vissp\u0113c\u012bg\u0101kie pier\u0101d\u012bjumi par fibromial\u0123iju, ce\u013ca loc\u012btavas osteoartr\u012bta invalidit\u0101ti un kognit\u012bvajiem trauc\u0113jumiem. PBM protokoli bija \u013coti at\u0161\u0137ir\u012bgi - nav vienota standarta, kas apgr\u016btina sal\u012bdzin\u0101m\u012bbu. GRADE kvalit\u0101te: 17% vid\u0113ja, 57% zema, 26% \u013coti zema.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM hronisku s\u0101pju gad\u012bjum\u0101: sistem\u0101tisks RCT apskats<\/strong><br><em>Integrat\u012bv\u0101s neirozin\u0101tnes robe\u017eas (2026)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/integrative-neuroscience\/articles\/10.3389\/fnint.2026.1717372\/full\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14 RCT, 6611 p\u0101rbaud\u012bti raksti. Vissp\u0113c\u012bg\u0101kie rezult\u0101ti fibromial\u0123ijai un perif\u0113raj\u0101m neirop\u0101tij\u0101m: VAS samazin\u0101jums noz\u012bm\u012bgs (p = 0,010), jut\u012bgie punkti iev\u0113rojami samazin\u0101ti (p &lt; 0,0001). Ieteicamie parametri neirop\u0101tisk\u0101m s\u0101p\u0113m: 660-830 nm, 40-80 mW\/cm\u00b2, 4-6 J\/cm\u00b2, 3 reizes ned\u0113\u013c\u0101.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Fibromyalgie\"><\/span>Fibromial\u0123ija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBMT efektivit\u0101te fibromial\u0123ijas gad\u012bjum\u0101: sistem\u0101tisks p\u0101rskats (17 p\u0113t\u012bjumi)<\/strong><br><em>MDPI Lieti\u0161\u0137\u0101s zin\u0101tnes (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2076-3417\/15\/8\/4161\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">857 dal\u012bbnieki. Izmantot\u0101s ier\u012bces: zema l\u012bme\u0146a l\u0101zers, infrasarkanais LED, visa \u0137erme\u0146a gaismas gultas (NovoTHOR). Visa \u0137erme\u0146a PBM (630-1 100 nm, main\u012bga fluence 1-150 J\/cm\u00b2) bija vismaz l\u012bdzv\u0113rt\u012bga lokaliz\u0113tai PBM. Meh\u0101nisms: oksidat\u012bv\u0101 stresa, mitohondriju funkcijas un nocicept\u012bvo sign\u0101lu ce\u013cu modul\u0101cija. Ieteikums: Visam \u0137ermenim v\u0113lama pieeja pla\u0161i izplat\u012btiem s\u0101pju punktiem.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Visa \u0137erme\u0146a PBM ietekme uz s\u0101p\u0113m, QoL, kineziofobiju: tr\u012bsk\u0101r\u0161i akls RCT, 6 m\u0113ne\u0161u nov\u0113ro\u0161ana<\/strong><br><em>Neirozin\u0101tnes robe\u017eas (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/10.3389\/fnins.2024.1264821\/full\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">42 pacienti, NovoTHOR visa \u0137erme\u0146a gulta (660 + 850 nm, patent\u0113ts jaudas bl\u012bvums). 12 \u0101rst\u0113\u0161anas sesijas. Iev\u0113rojams s\u0101pju samazin\u0101jums T2 (p\u0113c terapijas), T3 (2 ned\u0113\u013cu nov\u0113ro\u0161ana) un T4\/T5 (3 un 6 m\u0113ne\u0161i). Visa \u0137erme\u0146a PBM iedarbojas uz sist\u0113misku fibromial\u0123ijas patolo\u0123iju efekt\u012bv\u0101k nek\u0101 selekt\u012bva piem\u0113ro\u0161ana.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kniearthrose_Tendinopathie\"><\/span>Ce\u013ca osteoartr\u012bts un tendinop\u0101tija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM ce\u013ca loc\u012btavas osteoartr\u012bta \u0101rst\u0113\u0161anai: sistem\u0101tisks p\u0101rskats un metaanal\u012bze (10 RCT)<\/strong><br><em>Fizik\u0101l\u0101 terapija (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38775202\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">542 dal\u012bbnieki. Visefekt\u012bv\u0101kie parametri: 810-830 nm, 50-100 mW\/cm\u00b2, 4-10 J\/cm\u00b2 uz ce\u013ca loc\u012btavas, 10-20 min, 3 reizes ned\u0113\u013c\u0101. M\u0113reni pier\u0101d\u012bjumi par s\u0101pju samazin\u0101\u0161anos un funkcion\u0101lo uzlabojumu. Piez\u012bme: ce\u013ca loc\u012btava atrodas dzi\u013c\u0101k nek\u0101 \u0101das virsma, t\u0101p\u0113c priek\u0161roka dodama 810-850 nm (dzi\u013c\u0101ka iek\u013c\u016b\u0161ana), nevis 660 nm.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neuropathischer_Schmerz\"><\/span>Neirop\u0101tisk\u0101s s\u0101pes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM neirop\u0101tisko s\u0101pju gad\u012bjum\u0101: meh\u0101nismi, pier\u0101d\u012bjumi un n\u0101kotnes virzieni<\/strong><br><em>Frontiers in Photonics (2025)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/photonics\/articles\/10.3389\/fphot.2025.1730347\/full\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">660 nm aktiviz\u0113 citus fotoakceptatorus nek\u0101 810-850 nm. Virspus\u0113jai neirop\u0101tijai (piem\u0113ram, p\u0113cherp\u0113tiska neiral\u0123ija): 660 nm, 20-50 mW\/cm\u00b2, 4-6 J\/cm\u00b2. Dzi\u013cai neirop\u0101tijai (piem\u0113ram, diab\u0113tiskai polineirop\u0101tijai): 810-830 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2. Meh\u0101nisms: PBM induc\u0113 neiroprotekt\u012bvo iedarb\u012bbu, izmantojot BDNF sint\u0113zi un neiroinflam\u0101cijas nom\u0101k\u0161anu.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_AMD\"><\/span>Oftalmolo\u0123ija (AMD)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u012apa\u0161i doz\u0113\u0161anas noteikumi attiecas uz acu lietojumiem (\u012bpa\u0161i AMD): T\u012bklenes apstarojums (tas, kas faktiski sasniedz t\u012bkleni) ir iev\u0113rojami maz\u0101ks nek\u0101 ier\u012bces jaudas bl\u012bvums. T\u0101das ier\u012bces k\u0101 fotobiomodul\u0101cijas brilles (LumiThera) izstaro gaismu caur z\u012bl\u012bti - tie\u0161i uz makulu. T\u0101p\u0113c var pietikt tikai ar 0,3-15 \u03bcW\/cm\u00b2 t\u012bklenes izstarojumu. Uzman\u012bbu: nepareiza deva var izrais\u012bt t\u012bklenes boj\u0101jumus. Izmantojiet tikai apstiprin\u0101t\u0101s oftalmolo\u0123isk\u0101s PBM ier\u012bces!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 590 nm + 660 nm + 850 nm (vair\u0101ku vi\u013c\u0146u garumu, piem\u0113ram, LIGHTSITE III)<\/li>\n\n\n\n<li>Jaudas bl\u012bvums 0,3-15 \u03bcW\/cm\u00b2 (t\u012bklenes); ier\u012bces virsmas laukums ~ 600 \u03bcW\/cm\u00b2.<\/li>\n\n\n\n<li>\u013boti zems ener\u0123ijas bl\u012bvums, r\u016bp\u012bgi kalibr\u0113ts<\/li>\n\n\n\n<li>Ilgums 3-10 min\/sesija, 3 reizes ned\u0113\u013c\u0101 3-13 m\u0113ne\u0161u laik\u0101<\/li>\n\n\n\n<li>Ilgtermi\u0146a lieto\u0161ana; p\u0101rbaudiet ik p\u0113c 3 m\u0113ne\u0161iem<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Altersbedingte_Makuladegeneration\"><\/span>Ar vecumu saist\u012bta makulas de\u0123ener\u0101cija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>LIGHTSITE III: PBM (590+660+850 nm) ar sauso AMD<\/strong><br><em>RETINA \u017eurn\u0101ls (2024)<\/em> <a href=\"https:\/\/journals.lww.com\/retinajournal\/fulltext\/2024\/03000\/lightsite_iii__13_month_efficacy_and_safety.14.aspx\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">100 pacienti, 10 ASV centri, 13 m\u0113ne\u0161i. Ier\u012bce: LumiThera Valeda gaismas pieg\u0101des sist\u0113ma. Vi\u013c\u0146a garums: 590 + 660 + 850 nm sec\u012bgi. \u0100rst\u0113\u0161ana: 3 reizes ned\u0113\u013c\u0101 3 m\u0113ne\u0161us, p\u0113c tam atk\u0101rtoti \u0101rst\u0113\u0161anas cikli. Rezult\u0101ts: +5,4 burtu redzes asums (ETDRS) sal\u012bdzin\u0101jum\u0101 ar fikt\u012bvo, &lt;1% jauna \u0123eogr\u0101fisk\u0101 atrofija sal\u012bdzin\u0101jum\u0101 ar 9,8% fikt\u012bvaj\u0101 da\u013c\u0101 - statistiski \u013coti noz\u012bm\u012bgi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM4AMD: \u012bstermi\u0146a efektivit\u0101te agr\u012bn\u0101\/vid\u0113ji agr\u012bn\u0101 AMD stadij\u0101<\/strong><br><em>Acs (daba) (2024)<\/em> <a href=\"https:\/\/www.nature.com\/articles\/s41433-024-03326-4\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">38 dal\u012bbnieki, 12 ned\u0113\u013cas. Parametri: Vair\u0101ku vi\u013c\u0146u garums (l\u012bdz\u012bgi k\u0101 LIGHTSITE), 10 min\/sesija, 3 reizes ned\u0113\u013c\u0101. Redzes asums, kontrasta jut\u012bba un adapt\u0101cija tums\u0101 iev\u0113rojami uzlaboj\u0101s. Dro\u0161\u012bba: nav termiskas vai struktur\u0101las blakuspar\u0101d\u012bbas t\u012bklenei.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM lieto\u0161ana oftalmolo\u0123ij\u0101: no darbagalda l\u012bdz gultasvietai<\/strong><br><em>Frontiers in Ophthalmology (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/ophthalmology\/articles\/10.3389\/fopht.2024.1388602\/full\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Paskaidro sare\u017e\u0123\u012bto parametru situ\u0101ciju oftalmolo\u0123ij\u0101: noteico\u0161ais ir t\u012bklenes izstarojums, nevis ier\u012bces jauda. Da\u017e\u0101dos AMD p\u0113t\u012bjumos ar 630 nm jau ir konstat\u0113ti b\u016btiski t\u012bklenes uzlabojumi pie 15 \u03bcW\/cm\u00b2. Nav blakuspar\u0101d\u012bbu 15 gadu laik\u0101 ar pareizu doz\u0113\u0161anu - svar\u012bgi: izmantojiet tikai kalibr\u0113tas medic\u012bnas ier\u012bces ar acu speci\u0101liem apstiprin\u0101jumiem.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_Mukositis\"><\/span>Onkolo\u0123ija un mukoz\u012bts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Mutes g\u013cot\u0101das iekaisums ir visbie\u017e\u0101k sastopam\u0101 ak\u016bt\u0101 \u0137\u012bmijterapijas\/radioterapijas blakuspar\u0101d\u012bba. PBM lieto intraor\u0101li uz mutes g\u013cot\u0101das k\u0101 profilaktisku l\u012bdzekli (pirms v\u0113\u017ea terapijas un t\u0101s laik\u0101). Saska\u0146\u0101 ar MASCC\/ISOO vadl\u012bnij\u0101m (2019) PBM ir vien\u012bg\u0101 nefarmakolo\u0123isk\u0101 intervence ar ofici\u0101lu ieteikumu (A l\u012bmenis) mukoz\u012bta profilaksei hematopo\u0113tisko cilmes \u0161\u016bnu transplant\u0101cijas gad\u012bjum\u0101. \u0160aj\u0101 jom\u0101 vi\u013c\u0146u garums un devas ir visstandartiz\u0113t\u0101k\u0101s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 630-660 nm (intraor\u0101li); 650 + 980 nm (kombin\u0113ti intra+ekstraor\u0101li)<\/li>\n\n\n\n<li>Jaudas bl\u012bvums 10-25 mW\/cm\u00b2 (MASCC\/ISOO iesaka InGaAlP l\u0101zerus 10-25 mW).<\/li>\n\n\n\n<li>Ener\u0123ijas bl\u012bvums 2-6 J\/cm\u00b2 uz g\u013cot\u0101das punktu<\/li>\n\n\n\n<li>Ilgums 3-5 min\/punkts<br>Lieto katru dienu vai p\u0101rmai\u0146us v\u0113\u017ea terapijas laik\u0101<\/li>\n\n\n\n<li>Bie\u017eums Ikdien\u0101 \u0137\u012bmijterapijas\/radioterapijas laik\u0101; vismaz 5 reizes ned\u0113\u013c\u0101<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Leitlinien\"><\/span>Vadl\u012bnijas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>MASCC\/ISOO kl\u012bnisk\u0101s prakses vadl\u012bnijas attiec\u012bb\u0101 uz PBM un mutes g\u013cot\u0101du<\/strong><br><em>Atbalsta apr\u016bpe v\u0113\u017ea slimniekiem (2019)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00520-019-04890-2\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ofici\u0101ls ieteikums (augst\u0101kais pier\u0101d\u012bjumu l\u012bmenis): Vi\u013c\u0146a garums 632-685 nm (He-Ne vai InGaAlP), jauda 10-25 mW, ener\u0123ijas bl\u012bvums 2-4 J\/cm\u00b2 uz vienu aplik\u0101cijas punktu, intraor\u0101li uz slimaj\u0101m viet\u0101m. Bie\u017eums: katru dienu \u0137\u012bmijterapijas laik\u0101. Piem\u0113ro: hematopo\u0113tisko cilmes \u0161\u016bnu transplant\u0101cijai, galvas un kakla \u0137\u012bmijterapijai. P\u0113c 15 gadu ilgas nov\u0113ro\u0161anas nav b\u016btisku blakuspar\u0101d\u012bbu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Chemotherapie-induzierte_Mukositis\"><\/span>\u0136\u012bmijterapijas izrais\u012bts mukoz\u012bts<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Profilaktisk\u0101 PBM \u0137\u012bmijterapijas izrais\u012bta mutes g\u013cot\u0101das mukoz\u012bta gad\u012bjum\u0101: sistem\u0101tisks RCT apskats<\/strong><br><em>MDPI Biomedicines (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2227-9059\/13\/2\/268\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">13 p\u0113t\u012bjumi, 828 pacienti. Izmantotie parametri: 630-660 nm InGaAlP diodes l\u0101zers, 10-25 mW, 2-6 J\/cm\u00b2, intraor\u0101li katru dienu. Mukoz\u012bts att\u012bst\u012bj\u0101s 211 pret 128 pacientiem (kontrole pret PBM). 85% p\u0113t\u012bjumiem bija zems neobjektivit\u0101tes risks. Profilaktisk\u0101 PBM iev\u0113rojami p\u0101r\u0101ka par reakt\u012bvo \u0101rst\u0113\u0161anu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM prekondicion\u0113\u0161ana mutes g\u013cot\u0101das iekaisuma \u0101rst\u0113\u0161anai: dubultmask\u0113ta RCT<\/strong><br><em>BMC Oral Health (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11800611\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">45 pacienti, 3 grupas. 2. grupa: intraor\u0101l\u0101 650 nm (4 J\/cm\u00b2). grupa: intraor\u0101lais 650 nm + ekstraor\u0101lais 980 nm. Ab\u0101s intervences grup\u0101s tika konstat\u0113ta noz\u012bm\u012bga mukoz\u012bta un kserostomijas profilakse. Rezult\u0101ts: sarkan\u0101s + infrasarkan\u0101s gaismas (650 + 980 nm) kombin\u0101cija ir maksim\u0101li efekt\u012bva, lai piln\u012bb\u0101 p\u0101rkl\u0101tu mutes dobumu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kopf-Hals-Karzinome_Strahlentherapie\"><\/span>Galvas un kakla v\u0113zis un staru terapija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM mutes g\u013cot\u0101das mukoz\u012bta \u0101rst\u0113\u0161anai galvas un kakla v\u0113\u017ea gad\u012bjum\u0101: 14 RCT metaanal\u012bze<\/strong><br><em>Galva un kakls (Wiley) (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265122\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">869 pacienti. Parametru anal\u012bze: He-Ne un InGaAlP l\u0101zers (630-660 nm), 10-25 mW, 2-6 J\/cm\u00b2, ikdienas lieto\u0161ana staru terapijas laik\u0101 uzr\u0101d\u012bja vislab\u0101kos rezult\u0101tus. Relat\u012bvais mukoz\u012bta riska samazin\u0101jums: RR = 0,49 (p = 0,04) no 2. ned\u0113\u013cas. S\u0101pju samazin\u0101jums: WMD = -1,09 (p &lt; 0,00001). \u013boti noz\u012bm\u012bga efektivit\u0101te 7 staru terapijas ned\u0113\u013cu laik\u0101.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunsystem_Entzundung\"><\/span>Im\u016bnsist\u0113ma un iekaisums<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">PBM ietekm\u0113 im\u016bnsist\u0113mu atkar\u012bb\u0101 no konteksta: Iekaisu\u0161os audos tam ir pretiekaisuma iedarb\u012bba (samazina TNF-\u03b1, IL-6, IL-1\u03b2; veicina M2 makrof\u0101gu polariz\u0101ciju), veselos audos tam ir stimul\u0113jo\u0161a iedarb\u012bba. Im\u016bnmodul\u0113jo\u0161\u0101 iedarb\u012bba ir pier\u0101d\u012bta optisk\u0101 loga (650-950 nm) robe\u017e\u0101s, ar devas koridoru 1-10 J\/cm\u00b2. Svar\u012bgi: \u0161\u012bs devas ir iev\u0113rojami maz\u0101kas nek\u0101 musku\u013cu lietojumiem - im\u016bnsist\u0113ma rea\u0123\u0113 jut\u012bg\u0101k.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametri<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vi\u013c\u0146a garums 650-950 nm (vispla\u0161\u0101kais efekt\u012bvais spektrs; ieteicama 660 + 850 nm kombin\u0101cija)<\/li>\n\n\n\n<li>Jaudas bl\u012bvums 20-80 mW\/cm\u00b2<\/li>\n\n\n\n<li>Ener\u0123ijas bl\u012bvums 1-10 J\/cm\u00b2 (im\u016bnmodul\u0101cija)<br>Liel\u0101k\u0101m dev\u0101m var b\u016bt im\u016bnsupres\u012bva iedarb\u012bba.<\/li>\n\n\n\n<li>Ilgums 5-15 min\/sesija<\/li>\n\n\n\n<li>3 reizes ned\u0113\u013c\u0101; ak\u016bta iekaisuma gad\u012bjum\u0101 katru dienu pirmaj\u0101 ned\u0113\u013c\u0101<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunmodulation\"><\/span>Im\u016bnmodul\u0101cija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM imunomodul\u0113jo\u0161\u0101 iedarb\u012bba: visaptvero\u0161s p\u0101rskats<\/strong><br><em>L\u0101zeri medic\u012bnas zin\u0101tn\u0113 (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11991943\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Optim\u0101lie parametri im\u016bnmodul\u0101cijai: 650-950 nm, 20-80 mW\/cm\u00b2, 1-10 J\/cm\u00b2. PBM ietekm\u0113 dendr\u012bt\u0161\u016bnas (migr\u0101cija, citok\u012bnu ra\u017eo\u0161ana), veicina makrof\u0101gu M2 polariz\u0101ciju un regul\u0113 T \u0161\u016bnu atbildes reakciju. Svar\u012bgs atkl\u0101jums: tikai 1 J\/cm\u00b2 ir pietiekams izm\u0113r\u0101mai imunolo\u0123iskai iedarb\u012bbai - iev\u0113rojami maz\u0101kas devas nek\u0101 ieteicam\u0101s devas musku\u013ciem\/kaulam.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM terapijas efektivit\u0101te s\u0101pju un iekaisuma \u0101rst\u0113\u0161an\u0101: literat\u016bras apskats<\/strong><br><em>PMC (2023)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10094541\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PBM 600-1 070 nm, ener\u0123ijas bl\u012bvums 1-150 J\/cm\u00b2. Optim\u0101lais iekaisuma nom\u0101k\u0161anas re\u017e\u012bms: 780-950 nm, 40-80 mW\/cm\u00b2, 4-10 J\/cm\u00b2, 3 reizes ned\u0113\u013c\u0101. Visa \u0137erme\u0146a PBM uzr\u0101d\u012bja sist\u0113misku im\u016bnsist\u0113mas iedarb\u012bbu: uzlaboj\u0101s miega kvalit\u0101te, r\u012bta st\u012bvums, samazin\u0101j\u0101s musku\u013cu krampji, psiholo\u0123iskie faktori. \u012apa\u0161i svar\u012bgi hronisk\u0101m iekaisuma sist\u0113misk\u0101m slim\u012bb\u0101m (piem\u0113ram, fibromial\u0123ijai, RA).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Gaismas parametru un PBM efektivit\u0101tes p\u0101rskats (Hamblin, Harvard)<\/strong><br><em>J. Biomed. Optics (PMC) (2021)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noopener\">Pilns teksts \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pamatdarbs parametru noteik\u0161anai (Hamblin\/Harvard). Galvenais apgalvojums: nav visp\u0101r\u0113jas vieno\u0161an\u0101s par optim\u0101lajiem parametriem - jaudas bl\u012bvums &lt; 100 mW\/cm\u00b2 un ener\u0123ijas bl\u012bvums 4-10 J\/cm\u00b2 m\u0113r\u0137a audos tiek uzskat\u012bts par vienpr\u0101t\u012bgu konservat\u012bvu ieteikumu. Divf\u0101zu dozas reakcija (Arndt-Schulz): \u0161\u016bnu stimul\u0101cija 0,5-10 J\/cm\u00b2, inhib\u012bcija virs ~30 J\/cm\u00b2. Audiem ar augstu mitohondriju saturu (musku\u013ci, nervi, sirds, smadzenes) nepiecie\u0161ams vair\u0101k ener\u0123ijas nek\u0101 audiem ar zemu mitohondriju saturu (\u0101da, c\u012bpslas, skrim\u0161\u013ci).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Empfehlungen\"><\/span>Kl\u012bniskie ieteikumi<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Fotobiomodul\u0101cija ir pirm\u0101 neinvaz\u012bv\u0101 terapijas metode ar pier\u0101d\u012btu kl\u012bnisko efektivit\u0101ti vismaz 7 da\u017e\u0101d\u0101s medic\u012bnas jom\u0101s. Pier\u0101d\u012bjumu sp\u0113ks ir at\u0161\u0137ir\u012bgs: Vissp\u0113c\u012bg\u0101kie dati ir par mutes g\u013cot\u0101das iekaisumu (MASCC\/ISOO vadl\u012bnijas), br\u016b\u010du dz\u012b\u0161anu (metaanal\u012bzes LoE I) un musku\u013cu re\u0123ener\u0101ciju sport\u0101. Smadze\u0146u\/neirolo\u0123ijas un AMD jomas ir \u013coti daudzsolo\u0161as, bet v\u0113l tiek att\u012bst\u012btas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Dosierungsregeln_Konsensus\"><\/span>Visp\u0101r\u012bgi doz\u0113\u0161anas noteikumi (vienpr\u0101t\u012bba)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Absorb\u0113t\u0101 deva<\/strong><br>5-50 d\u017eoulu vien\u0101 sesij\u0101 (ieteicamais daudzums: ~ 25 J).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vi\u013c\u0146a garums uz m\u0113r\u0137i<\/strong><br>660 nm \u0101dai\/virsmai<br>810-850 nm - musku\u013ciem\/loc\u012btav\u0101m\/dzi\u013cajiem audiem<br>1 050-1 064 nm smadzen\u0113m<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Jaudas bl\u012bvums uz dzi\u013cumu<\/strong><br>\u0100da 6-50 mW\/cm\u00b2<br>Musku\u013ci 50-100 mW\/cm\u00b2<br>Smadzenes (transkrani\u0101li) 25-285 mW\/cm\u00b2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Nov\u0113rojiet bif\u0101zijas<\/strong><br>Liel\u0101kas devas nav autom\u0101tiski lab\u0101kas.<br>- \u0100da: maks. 20 J\/cm\u00b2<br>- Neironi: ne vair\u0101k k\u0101 10 J\/cm\u00b2 uz m\u0113r\u0137a audiem.<br>- musku\u013ciem: ne vair\u0101k k\u0101 30-50 J\/cm\u00b2.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kombin\u0113t\u0101s ier\u012bces<\/strong> - 660 + 850 nm nodro\u0161ina vispla\u0161\u0101ko spektru; nepiecie\u0161ams ~ 50% ilg\u0101ks apstr\u0101des laiks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u0100rst\u0113\u0161anas interv\u0101ls<\/strong><br>Ikdien\u0101 l\u012bdz 3\u00d7 ned\u0113\u013c\u0101; ieteicamais p\u0101rtraukums ik p\u0113c 1-2 dien\u0101m \u0161\u016bnu atjauno\u0161anai.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Evidenzstarke_nach_Bereich\"><\/span>Pier\u0101d\u012bjumu stiprums pa jom\u0101m<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u013boti sp\u0113c\u012bgs (LoE I, WALT\/MASCC vadl\u012bnijas)<\/strong><br>- Mukoz\u012bts v\u0113\u017ea gad\u012bjum\u0101<br>- Br\u016b\u010du dz\u012b\u0161ana<br>- Kolag\u0113ns\/\u0101da<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sp\u0113c\u012bgs (LoE I, metaanal\u012bzes)<\/strong><br>- Musku\u013cu re\u0123ener\u0101cija<br>- Fibromial\u0123ija<br>- AMD<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>M\u0113reni (LoE II, RCT)<\/strong><br>- Ce\u013ca osteoartr\u012bts<br>- neirop\u0101tisk\u0101s s\u0101pes<br>- Izzi\u0146a (transkrani\u0101li)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Agr\u012bn\u0101 stadija (pirmskl\u012bniski\/pilotprojekti)<\/strong><br>- Detoksik\u0101cija, limf\u0101tisk\u0101 sist\u0113ma<br>- Ilgtermi\u0146a izdz\u012bvo\u0161ana p\u0113c v\u0113\u017ea<br>- 1 064 nm dzi\u013c\u0101s smadze\u0146u strukt\u016bras<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\"><\/span>Sazi\u0146a ar PBM lietot\u0101jiem - \u0101rstiem \/ kl\u012bnik\u0101m<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\"><\/span>Oftalmolo\u0123ija - saus\u0101 AMD (makulas de\u0123ener\u0101cija)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160\u012b ir kl\u012bniski vismodern\u0101k\u0101 un regul\u0113juma zi\u0146\u0101 dro\u0161\u0101k\u0101 joma. Ier\u012bce&nbsp;<strong>Valeda (LumiThera)<\/strong>&nbsp;ir CE sertific\u0113ts un kop\u0161 2018. gada ir apstiprin\u0101ts Eirop\u0101; FDA ir apstiprin\u0101ts no 2024. gada novembra.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Nodro\u0161in\u0101t\u0101js<\/th><th>Atra\u0161an\u0101s vieta<\/th><th>Saite<\/th><\/tr><\/thead><tbody><tr><td><strong>Makulas t\u012bklenes centrs<\/strong>&nbsp;(Prof. Dr. Hakan Kaymak - viens no pasaul\u0113 pieredz\u0113ju\u0161\u0101kajiem lietot\u0101jiem, veic ~10 % no vis\u0101m PBM proced\u016br\u0101m pasaul\u0113).<\/td><td>Diseldorfa<\/td><td><a href=\"https:\/\/augenchirurgie.clinic\/behandlungen\/photobiomodulation\" target=\"_blank\" rel=\"noopener\">oftalmolo\u0123ija.kl\u012bnika<\/a><\/td><\/tr><tr><td><strong>Oftalmologs Witten<\/strong>&nbsp;(Dr. Riha) - viena no pirmaj\u0101m praks\u0113m V\u0101cij\u0101<\/td><td>Witten \/ NRW<\/td><td><a href=\"https:\/\/www.augenarzt-witten.de\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">augenarzt-witten.de<\/a><\/td><\/tr><tr><td><strong>Oftalmologs Minhene<\/strong>&nbsp;(Dr. Augstens)<\/td><td>Minhene<\/td><td><a href=\"https:\/\/www.augenarzt-muc.de\/netzhaut\/behandlung\/valeda\/\" target=\"_blank\" rel=\"noopener\">oftalmologs-muc.de<\/a><\/td><\/tr><tr><td><strong>Oftalmologi Gerl &amp; kol\u0113\u0123i<\/strong>&nbsp;(Valeda programma)<\/td><td>Minhene<\/td><td><a href=\"https:\/\/www.augenklinik.de\/behandlung\/valeda\" target=\"_blank\" rel=\"noopener\">eyeclinic.com<\/a><\/td><\/tr><tr><td><strong>Dr. Riha oftalmolo\u0123ija<\/strong><\/td><td>V\u012bne \/ AT<\/td><td><a href=\"https:\/\/dr-riha.com\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">dr-riha.com<\/a><\/td><\/tr><tr><td><strong>Oftalmologi Bern\u0113<\/strong>&nbsp;(CH)<\/td><td>Berne \/ CH<\/td><td><a href=\"https:\/\/www.augenaerzte-bern.ch\/leistungen\/photobiomodulation-bei-altersbedingter-makuladegeneration\/\" target=\"_blank\" rel=\"noopener\">oftalmologi-bern.ch<\/a><\/td><\/tr><tr><td><strong>Bernes acu kl\u012bnika<\/strong>&nbsp;(Prof. Garvegs)<\/td><td>Berne \/ CH<\/td><td><a href=\"https:\/\/augenklinik-bern.ch\/fachpublikum\/amd-sprechstunde\/\" target=\"_blank\" rel=\"noopener\">eye-clinic-bern.ch<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Piez\u012bme:<\/strong>\u00a0Izmaksas parasti nesedz oblig\u0101t\u0101 vesel\u012bbas apdro\u0161in\u0101\u0161ana (IGeL).<br>LumiThera sav\u0101 t\u012bmek\u013ca vietn\u0113 pied\u0101v\u0101 mekl\u0113t citus Valeda centrus.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\"><\/span>Onkolo\u0123ija - mutes g\u013cot\u0101das iekaisums (\u0137\u012bmijterapijas\/radioterapijas sekas)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM mutes g\u013cot\u0101das iekaisuma profilaksei un \u0101rst\u0113\u0161anai ir balst\u012bta uz vadl\u012bnij\u0101m (MASCC\/ISOO), un to arvien bie\u017e\u0101k integr\u0113 onkolo\u0123isk\u0101s atbalsto\u0161\u0101s apr\u016bpes programm\u0101s. Pirmo reizi Eiropas kl\u012bnisk\u0101s vadl\u012bnijas tika izstr\u0101d\u0101tas 2025\/2026. gad\u0101.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Nodro\u0161in\u0101t\u0101js<\/th><th>Piez\u012bme<\/th><th>Saite<\/th><\/tr><\/thead><tbody><tr><td><strong>rj-laser.com<\/strong>&nbsp;- Zobu l\u0101zerterapijas platforma ar kl\u012bniskajiem protokoliem mukoz\u012bta \u0101rst\u0113\u0161anai<\/td><td>Specializ\u0113tais port\u0101ls DE\/AT\/CH<\/td><td><a href=\"https:\/\/rj-laser.com\/de\/lasertherapie-mukositis-chemotherapieinduziert\" target=\"_blank\" rel=\"noopener\">rj-laser.com<\/a><\/td><\/tr><tr><td><strong>V\u0113\u017ea inform\u0101cijas dienests (KID)<\/strong><\/td><td>Stingri iesaka PBM k\u0101 alternat\u012bvu mukoz\u012bta \u0101rst\u0113\u0161anai atbalsto\u0161as terapijas gad\u012bjum\u0101.<\/td><td><a href=\"https:\/\/www.krebsinformationsdienst.de\/fileadmin\/pdf-dateien\/informationsblaetter\/iblatt-mukositis-bei-krebs.pdf\" target=\"_blank\" rel=\"noopener\">krebsinformationsdienst.de<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Konkr\u0113tas kl\u012bnikas V\u0101cij\u0101, kas regul\u0101ri pied\u0101v\u0101 PBM g\u013cot\u0101das iekaisuma gad\u012bjum\u0101, reti kad to nep\u0101rprotami public\u0113 pacientu t\u012bmek\u013ca vietn\u0113s. \u0100rst\u0113\u0161ana parasti notiek k\u0101 da\u013ca no zobu atbalsto\u0161\u0101s apr\u016bpes lielos onkolo\u0123ijas centros (piem\u0113ram, universit\u0101tes slimn\u012bc\u0101s).<br>Ieteicams sazin\u0101ties ar \u0101rst\u0113jo\u0161o onkolo\u0123ijas centru vai \u017eok\u013cu un sejas \u0137irurgu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\"><\/span>Dermatolo\u0123ija - \u0101da, br\u016b\u010du dz\u012b\u0161ana, pinnes, psori\u0101ze<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM, izmantojot LED gaismas terapiju, ir ieviesta daudz\u0101s dermatolo\u0123iskaj\u0101s praks\u0113s un est\u0113tiskaj\u0101s kl\u012bnik\u0101s.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Nodro\u0161in\u0101t\u0101js<\/th><th>Atra\u0161an\u0101s vieta<\/th><th>Saite<\/th><\/tr><\/thead><tbody><tr><td><strong>Dermatolo\u0123ija Dr. Friedl<\/strong>&nbsp;- LED gaismas terapija (Medisol\u00ae) aknes, vitiligo, psori\u0101zes, \u0101das noveco\u0161an\u0101s, balt\u0101 \u0101das v\u0113\u017ea (PDT) \u0101rst\u0113\u0161anai.<\/td><td>Austrija<\/td><td><a href=\"https:\/\/www.dermatologie-friedl.de\/leistungen\/aesthetische-medizin\/led-lichttherapie-mit-medisol-lampe\" target=\"_blank\" rel=\"noopener\">dermatolo\u0123ija-friedl.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Turkl\u0101t daudzas est\u0113tisk\u0101s dermatolo\u0123ijas prakses un l\u0101zeru centri V\u0101cij\u0101 izmanto PBM (piem\u0113ram, ar Fotona sist\u0113m\u0101m). Iesak\u0101m mekl\u0113t \u201eLED gaismas terapijas dermatolo\u0123ija\u201c vai \u201ePBM dermatologs\u201c, nor\u0101dot atra\u0161an\u0101s vietu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zahnmedizin_MKG-Chirurgie\"><\/span>Zob\u0101rstniec\u012bba \/ sejas un \u017eok\u013cu \u0137irur\u0123ija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM pla\u0161i izmanto zob\u0101rstniec\u012bb\u0101, piem\u0113ram, temporomandibul\u0101ro loc\u012btavu s\u0101pju (CMD), p\u0113coper\u0101cijas br\u016b\u010du dz\u012b\u0161anas, implantu un g\u013cot\u0101das iekaisuma gad\u012bjumos. Ortodonti izmanto&nbsp;<strong>OrthoPulse\u00ae ier\u012bce<\/strong>&nbsp;lai pa\u0101trin\u0101tu zobu kust\u012bbas (pa\u0161aplik\u0101cija, aptuveni 600 \u20ac).<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Nodro\u0161in\u0101t\u0101js \/ port\u0101ls<\/th><th>Piez\u012bme<\/th><th>Saite<\/th><\/tr><\/thead><tbody><tr><td><strong>ZWP tie\u0161saist\u0113<\/strong>&nbsp;- KFO-PBM p\u0101rskats<\/td><td>Specializ\u0113ts port\u0101ls<\/td><td><a href=\"https:\/\/www.zwp-online.info\/zwpnews\/wirtschaft-und-recht\/recht\/photobiomodulation-in-der-kieferorthopadie\" target=\"_blank\" rel=\"noopener\">zwp-online.info<\/a><\/td><\/tr><tr><td><strong>Fotona l\u0101zera sist\u0113mas<\/strong>&nbsp;(Iesp\u0113jama izplat\u012bt\u0101ja\/kl\u012bnikas mekl\u0113\u0161ana)<\/td><td>Zob\u0101rstniec\u012bbas un medic\u012bnas PBM, LightWalker<\/td><td><a href=\"https:\/\/www.fotona.com\/de\/treatments\/6496\/photobiomodulation-und-schmerzbehandlung\/\" target=\"_blank\" rel=\"noopener\">fotona.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\"><\/span>Neirolo\u0123ija \/ psihiatrija - Alcheimera slim\u012bba, TBI, depresija (agr\u012bn\u0101 f\u0101ze)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160aj\u0101 jom\u0101 joproj\u0101m tiek veikti kl\u012bniskie p\u0113t\u012bjumi. Regul\u0101ri apstiprin\u0101ti pakalpojumi pacientiem V\u0101cij\u0101 joproj\u0101m ir reti sastopami, tom\u0113r pirmie centri un p\u0113t\u012bjumi jau past\u0101v.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Nodro\u0161in\u0101t\u0101js \/ port\u0101ls<\/th><th>Piez\u012bme<\/th><th>Saite<\/th><\/tr><\/thead><tbody><tr><td><strong>PBM-Photobiomodulation.eu<\/strong>&nbsp;- Eiropas inform\u0101cijas port\u0101ls ar praktisku p\u0101rskatu<\/td><td>DACH re\u0123ions<\/td><td><a href=\"https:\/\/pbm-photobiomodulation.eu\/PBM\" target=\"_blank\" rel=\"noopener\">pbm-photobiomodulation.eu<\/a><\/td><\/tr><tr><td><strong>Neirofeedback Luksemburga<\/strong>&nbsp;- inform\u0113 par neirolo\u0123isk\u0101m PBM lietojumprogramm\u0101m.<\/td><td>LU\/DACH<\/td><td><a href=\"https:\/\/neurofeedback-luxembourg.com\/de\/photobiomodulation-ein-umfassender-leitfaden-fur-lichttherapievorteile\/\" target=\"_blank\" rel=\"noopener\">neurofeedback-luxembourg.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Suchwerkzeuge\"><\/span>Visp\u0101r\u0113jie mekl\u0113\u0161anas r\u012bki<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ra\u017eot\u0101js LumiThera sav\u0101 t\u012bmek\u013ca vietn\u0113 pied\u0101v\u0101\u00a0<strong>Atra\u0161an\u0101s vietas mekl\u0113\u0161ana<\/strong>\u00a0Valeda praksei:\u00a0<a href=\"https:\/\/www.lumithera.com\/\" target=\"_blank\" rel=\"noopener\">lumithera.com<\/a><\/li>\n\n\n\n<li>Port\u0101ls\u00a0<strong>pbm-photobiomodulation.eu<\/strong>\u00a0uzskaita Eiropas praksi<\/li>\n\n\n\n<li>Port\u0101ls\u00a0<strong>Pasaules L\u0101zerterapijas asoci\u0101cija (WALT)<\/strong>\u00a0pied\u0101v\u0101 glob\u0101lu terapeita mekl\u0113\u0161anu<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Svar\u012bga piez\u012bme:<\/strong>\u00a0Vairumam PBM indik\u0101ciju (iz\u0146emot atbalsta onkolo\u0123iju da\u017eos centros) V\u0101cij\u0101 v\u0113l nav regul\u0113ta izmaksu seg\u0161ana no oblig\u0101t\u0101s vesel\u012bbas apdro\u0161in\u0101\u0161anas fondiem.<br>PBM galvenok\u0101rt izmanto k\u0101\u00a0<strong>IGeL pakalpojums<\/strong>\u00a0r\u0113\u0137ins tiek izrakst\u012bts priv\u0101ti.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Dokuments ir balst\u012bts uz recenz\u0113to literat\u016bru no PubMed, PMC, Frontiers, MDPI, Springer un Nature laika posm\u0101 no 2019. l\u012bdz 2026. gada 2. febru\u0101rim. <\/em><br>Att\u0113lots <em>Parametri ir \u0146emti no kl\u012bniskajiem p\u0113t\u012bjumiem un WALT\/MASCC ieteikumiem.<\/em><\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Viss saturs ir r\u016bp\u012bgi izp\u0113t\u012bts un atspogu\u013co pa\u0161reiz\u0113jo (02.2026.) public\u0113to zin\u0101\u0161anu l\u012bmeni. Tas ir paredz\u0113ts tikai informat\u012bviem nol\u016bkiem un neaizst\u0101j profesion\u0101lu \u0101rsta konsult\u0101ciju.<br><br>Saist\u012btie p\u0113t\u012bjumi sniedz \u0101rstam papildu medic\u012bnisko un zin\u0101tnisko inform\u0101ciju.<\/p>\n<\/blockquote>","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Las\u012b\u0161anas laiks<\/span> <span class=\"rt-time\"> 12<\/span> <span class=\"rt-label rt-postfix\">protokols<\/span><\/span>Umfassende Studien\u00fcbersicht 2023\u20132025 Einleitung Photobiomodulation (PBM), auch bekannt als Low-Level-Lasertherapie (LLLT), ist eine nicht-invasive therapeutische Methode, die Licht bestimmter Wellenl\u00e4ngen nutzt, um biologische Prozesse in lebendem Gewebe zu stimulieren.Prim\u00e4rer Mechanismus ist die Absorption von Photonen durch den mitochondrialen Photoakzeptor Cytochrom-c-Oxidase (CCO), was die ATP-Synthese steigert, reaktive Sauerstoffspezies moduliert und eine Kaskade zellul\u00e4rer Regenerationsprozesse anst\u00f6\u00dft. Das&hellip;&nbsp;<a href=\"https:\/\/csiag.eu\/lv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/\" rel=\"bookmark\">Las\u012bt vair\u0101k \"<span class=\"screen-reader-text\">Fotobiomodul\u0101cija (PBM)<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-12784","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/posts\/12784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/comments?post=12784"}],"version-history":[{"count":0,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/posts\/12784\/revisions"}],"wp:attachment":[{"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/media?parent=12784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/categories?post=12784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.eu\/lv\/wp-json\/wp\/v2\/tags?post=12784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}